LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

Relative Value

The Relative Value of one LVTX stock under the Base Case scenario is 2.16 USD. Compared to the current market price of 1.66 USD, LAVA Therapeutics NV is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LVTX Relative Value
Base Case
2.16 USD
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
41
vs Industry
68
Median 3Y
6.5
Median 5Y
6.4
Industry
8.1
Forward
12.2
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-2
Industry
23
Forward
-1.4
vs History
vs Industry
10
Median 3Y
-2.5
Median 5Y
-3.7
Industry
23.4
vs History
vs Industry
8
Median 3Y
-2.4
Median 5Y
-3.7
Industry
27.3
vs History
36
vs Industry
60
Median 3Y
1.1
Median 5Y
1.1
Industry
2.6
vs History
vs Industry
74
Median 3Y
-2.9
Median 5Y
-3.2
Industry
8.1
Forward
-10.5
vs History
vs Industry
68
Median 3Y
-260.1
Median 5Y
0
Industry
9.6
vs History
28
vs Industry
15
Median 3Y
1
Median 5Y
0.6
Industry
4.3
Forward
1.3
vs History
28
vs Industry
13
Median 3Y
1
Median 5Y
0.6
Industry
3.8
Forward
1.1
vs History
23
vs Industry
19
Median 3Y
-1
Median 5Y
-8.8
Industry
6
vs History
23
vs Industry
15
Median 3Y
-1
Median 5Y
-10.3
Industry
3.8
vs History
vs Industry
32
Median 3Y
-10.5
Median 5Y
-5.5
Industry
4.8

Multiples Across Competitors

LVTX Competitors Multiples
LAVA Therapeutics NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
LAVA Therapeutics NV
NASDAQ:LVTX
43.7m USD 5.9 -1.8 1.4 1.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 678 545.3 -179 080.5 -217 460.8 -214 979.3
US
Abbvie Inc
NYSE:ABBV
299.8B USD 5.4 59 14.8 22.7
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.6 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD 11.7 -259.9 26.3 27.6
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 4.1 910.9 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 869.7 -477.1 -519.6 -505.7
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.5 20.7 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 6.2 18.5 17 18.9
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.2 -59.4 -53.6
NL
argenx SE
XBRU:ARGX
34B EUR 18.4 -129.2 -103.9 -75.7
P/E Multiple
Earnings Growth
NL
LAVA Therapeutics NV
NASDAQ:LVTX
Average P/E: 211.9
Negative Multiple: -1.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 080.5 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -259.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477.1 N/A
AU
CSL Ltd
ASX:CSL
33.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.2 N/A
EV/EBITDA Multiple
EBITDA Growth
NL
LAVA Therapeutics NV
NASDAQ:LVTX
Average EV/EBITDA: 15.4
1.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 460.8 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -519.6 N/A
AU
CSL Ltd
ASX:CSL
20.7
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.9 N/A
EV/EBIT Multiple
EBIT Growth
NL
LAVA Therapeutics NV
NASDAQ:LVTX
Average EV/EBIT: 19.9
1.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 979.3 N/A
US
Abbvie Inc
NYSE:ABBV
22.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
25.8
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.7 N/A

See Also

Discover More
Back to Top